Link Fund Solutions’s Theravance Biopharma TBPH Stock Holding History

Link Fund Solutions’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,836,864	Closed	-$111M	–	1
2020 Q1	$111M	Sell	4,836,864 -414,485	-8%	-$10.4M	71%	1
2019 Q4	$135M	Buy	+5,251,349	New	+$102M	69.86%	1

Other funds holding TBPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Link Fund Solutions's TBPH Position: Q2 2020 in Review

Link Fund Solutions sold out of Theravance Biopharma (TBPH) in Q2 2020, closing a stake of 4,836,864 shares — an estimated $111M sold.

Link Fund Solutions first reported a position in TBPH in Q4 2019 and held it in 2 quarters. The position peaked at $135M in Q4 2019. 125 funds tracked by Wall St. Rank hold TBPH as of Q2 2020.

Link Fund Solutions reported no remaining Theravance Biopharma position as of Q2 2020 after selling out during the quarter.
Link Fund Solutions sold 4,836,864 Theravance Biopharma shares in Q2 2020, an estimated $111M.
Link Fund Solutions first reported a position in Theravance Biopharma in Q4 2019 and held it in 2 quarters.
Link Fund Solutions's Theravance Biopharma position peaked at $135M in Q4 2019.
125 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2020.

Based on Link Fund Solutions's 13F filing for Q2 2020.